Production (Stage)
Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -374.13% | 11.02% | |||
| Gross Profit | 374.13% | -11.02% | |||
| SG&A Expenses | -25.67% | 0.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -24.46% | 2.69% | |||
| Operating Income | 24.46% | -2.69% | |||
| Income Before Tax | 38.79% | -2.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 38.79% | -2.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 38.79% | -2.67% | |||
| EBIT | 24.46% | -2.69% | |||
| EBITDA | 45.95% | -5.14% | |||
| EPS Basic | 33.79% | -2.06% | |||
| Normalized Basic EPS | 38.87% | -2.40% | |||
| EPS Diluted | 33.79% | -2.06% | |||
| Normalized Diluted EPS | 38.87% | -2.40% | |||
| Average Basic Shares Outstanding | 0.03% | 0.35% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||